Assessment on beta-blocker interruption effects on safety and efficacy in myocardial infarction survivors, suggesting important implications for patient care.
The appropriate duration of treatment with beta-blocker drugs after a myocardial infarction is unknown. Data are needed on the safety and efficacy of the interruption of long-term beta-blocker treatment to reduce side effects and improve quality of life in patients with a history of uncomplicated myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Silvain et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: